Ecteinascidins: Putative biosynthetic precursors and absolute stereochemistry

Journal of the American Chemical Society

Volumn 118, Issue 38, 1996, Pages 9017-9023

  Sakai, Ryuichi ^a   Jares Erijman, Elizabeth A ^a   Manzanares, Ignacio ^b   Silva Elipe, Maria V ^a   Rinehart, Kenneth L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b PHARMAMAR S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ECTEINASCIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CELL LINE; CHIRALITY; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INVERTEBRATE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN ISOLATION; PROTEIN STRUCTURE; TUMOR CELL;

EID: 0029831192     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja950054m     Document Type: Article

References (34)

1. (a) Holt, T. G. Ph.D. Thesis, University of Illinois, Urbana, 1986; Diss. Abstr. Int. B 1987, 47, 3771-3772; Chem. Abstr. 1987, 106, 193149u.
2. (a) Holt, T. G. Ph.D. Thesis, University of Illinois, Urbana, 1986; Diss. Abstr. Int. B 1987, 47, 3771-3772; Chem. Abstr. 1987, 106, 193149u.
3. (a) Holt, T. G. Ph.D. Thesis, University of Illinois, Urbana, 1986; Diss. Abstr. Int. B 1987, 47, 3771-3772; Chem. Abstr. 1987, 106, 193149u.
4. (b) Rinehart, K. L.; Holt, T. G. U.S. Patent 5,089,273, Feb. 18, 1992; Chem. Abstr. 1992, 117, 63016q.
5. (b) Rinehart, K. L.; Holt, T. G. U.S. Patent 5,089,273, Feb. 18, 1992; Chem. Abstr. 1992, 117, 63016q.
6. (c) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Keifer, P. A.; Wilson, G. R.; Perun, T. J., Jr.; Sakai, R.; Thompson, A. G.; Stroh, J. G.; Shield, L. S.; Seigler, D. S. J. Nat. Prod. 1990, 53, 771-792.
7. (d) Sigel, M. M.; Wellham, L. L.; Lichter, W.; Dudeck, L. E.; Gargus, J. L.; Lucas, A. H. In Food-Drugs from the Sea Proceedings 1969; Younghen, Jr., H. W., Ed.; Marine Technology Soc.: Washington, D.C., 1969; pp 281-294.
8. (e) Lichter, L.; Ghaffar, A.; Wellham, L. L.; Sigel, M. M. In Drugs & Food from the Sea; Kaul, P. N.; Sindermann, C. J., Eds., University of Oklahoma: Norman, OK, 1978; pp 137-144.
9. (f) Sigel, M. M.; Lichter, W.; Wellham, L. L.; McCumber, L. J. 4th Intl. Symposium on Marine Natural Products. Tenerife, Spain, July 26-30, 1982, Abstract C-12.
10. (g) Sakai, R.; Rinehart, K. L.; Guan, Y.; Wang, A. H.-J. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11456-11460.
11. (h) Rinehart, K.; Sakai, R.; U.S. Patent 5,149,804; Sept. 22, 1992; Chem. Abstr. 1992, 117, 205189z.
12. (h) Rinehart, K.; Sakai, R.; U.S. Patent 5,149,804; Sept. 22, 1992; Chem. Abstr. 1992, 117, 205189z.
13. G. Faircloth, PharmaMar U.S., Cambridge, MA, personal communication to K. L. R.
14. (a) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.: Sun, F.; Li, L. H.; Martin, D. G. J. Org. Chem, 1990, 55, 4512-4515.
15. (b) Wright, A. E.; Forleo, D. A.; Gunawardana, P. G.; Gunasekera, S. P.; Koehn, F. E.; McConnell, O. J. J. Org. Chem. 1990, 55, 4508-4512.
16. (c) Guan, Y.; Sakai, R.; Rinehart, K. L.; Wang, A. H.-J. J. Biomol. Struc. Dynamics 1993, 10, 793-818.
17. (d) Sakai, R., Ph.D. Thesis, University of Illinois, Urbana, 1991.
18. (a) Arai, T.; Takahashi, K.; Kubo, A. J. Antibiot. 1977, 30, 1015-1018.
19. (b) Ikeda, Y.; Idemoto, H.; Hirayama, F.; Yamamoto, K.; Iwao, K.; Asao, T.; Munakata, T. J. Antibiot. 1983, 36, 1279-1283.
20. (a) Remers, W. A. The Chemistry of Antitumor Antibiotics; Wiley: New York, 1988; Vol 2, pp 93-119.
21. (b) He, H.-Y.; Faulkner, D. J. J. Org. Chem. 1989, 54, 5822-5824.
22. 3d
23. The present compounds (1-4) have been briefly described in a meeting report: Rinehart, K. L.; Tachibana, K. J. Nat. Prod. 1995, 58, 344-358.
24. - by negative FABMS failed (see ref le).
25. Signal broadening in medium-sized rings has been commonly observed for marine polyethers; cf. Murata, M.; Legrand, A. M.; Ishibashi, Y.; Yasumoto, T. J. Am. Chem. Soc. 1989, 111, 8929-8931.
26. 11
27. Magic bullet contains 10% methanol; cf. Witten, J. L.; Schaffer, M. H.; O'Shea, M.; Cook, J. C.; Hemling, M. E.; Rinehart, K. L., Jr. Biochem. Biophys. Res. Commun. 1984, 106, 811-813.
28. IR absorption for the aα-keto group is expected to be small, since compound 1 exists mostly as the hemiketal or ketal in solution, as evidenced by FABMS. In the solid form, it may also exist, at least in part, as the hemiketal or ketal form.
29. Mikami, Y.; Takahashi, K.; Yazawa, K.; Arai, T.; Namikoshi, M.; Iwasaki, S.; Okuda, S. Biol. Chem. 1985, 260, 344-348.
30. (a) Kerr, R. G.; Miranda, N. F. J. Nat. Prod. 1995, 58, 1616-1621.
31. (b) Morales, J. J.; Rinehart, K. L. 1995 International Chemistry Congress Pacific Basin Societies. Honolulu, Dec 17-22, 1995. Abstract ORGN 184.
32. Enzymatic reactions to form a methylenedioxy bridge have been demonstrated for plant-derived tetrahydroisoquinolines; cf. Bauer, W.; Zenk, M. H. Phytochemistry 1991, 30, 2953-2961.
33. Guan, Y.; Sakai, R.: Rinehart, K. L.: Wang, A. H.-J. J. Biomol. Struct. Dyn. 1993, 10, 793-818.
34. Ishiguro, K.; Sakiyama, S.; Takahashi, K.; Arai, T. Biochemistry 1978, 17, 2545-2550.